The role of genomics in treating prostate cancer - a discussion with Dr. Todd Cohen
Play • 19 min

In this episode, Dr. Slavin welcomes Dr. Todd Cohen, Vice President of Medical Affairs for the Myriad Urology department. Dr. Cohen formerly practiced with Hawes Urology before pursuing an academic role as the Assistant Chairman of Urology at Ohio State University. He then co-founded Piedmont Urology in Charlotte, NC before forming Carolina Urology Partners, a merging of nine urology groups, where he acted as co-CEO, then CEO. Myriad Genetics welcomed Dr. Cohen in his leadership role in March of 2019.  Dr. Cohen brings his many years of expertise to the discussion regarding genomics, the role of gene expression assays, and the treatment of prostate cancer. 

Clear search
Close search
Google apps
Main menu